Guijosa, A., Tsakmaklis, N., Kobs, M., Kofides, A., Guerrera, M. L., von Keudell, G., Branagan, A., Hunter, Z. R., Treon, S. P., Sarosiek, S., & Castillo, J. J. (2026). Off-trial outcomes of zanubrutinib in Waldenström macroglobulinemia: the prognostic impact of CXCR4 and TP53 alterations.. Leukemia, 40(3), 671-675.